Top in rheumatology: RA medication changes, sleep loss and inflammation
Click Here to Manage Email Alerts
Data revealed “substantial” medication changes among patients with rheumatoid arthritis amid the pandemic, with 30% reporting a medication change during the first 3 months. It was the top story in rheumatology last week.
Another top story explored a link between sleep loss and increased inflammation among patients with immune-mediated inflammatory diseases. Researchers said there is evidence that the relationship between sleep and the immune system is “bidirectional.”
Read these and more top stories in rheumatology below:
COVID-19 pandemic sparked 'substantial' drug changes in patients with rheumatoid arthritis
Patients with rheumatoid arthritis in the United States made “substantial” medication changes in the first 3 months of the COVID-19 pandemic, with and without physician guidance, according to data published in Arthritis Care & Research. Read more.
Sleep 'intimately tied' to increased inflammation, worse disease course in IMIDs
Experimental studies indicate that sleep loss can lead to elevated concentrations of proinflammatory cytokines and enhance the perception of pain among patients with immune-mediated inflammatory diseases. Read more.
New data offer 'first glimpse' of COVID-19 vaccine efficacy in IMIDs, rheumatic diseases
Emerging data are showing solid efficacy and safety of COVID-19 vaccines in individuals with rheumatic and immune-mediated diseases, according to a presentation at the United Rheumatology Spring Virtual conference. Read more.
Going viral: Squaring off against social media’s medical misinformation ‘infodemic’
If anyone still believed that social media is just a benign way for friends near and far to connect, that notion died with COVID-19. Read more.
Infliximab treatment for IBD linked to attenuated anti-COVID-19 antibody responses
Anti-COVID-19 antibody responses are attenuated in patients who receive infliximab for inflammatory bowel disease, according to a speaker at the 2021 Interdisciplinary Autoimmune Summit. Read more.